AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

The Global Market for Cardiac Biomarkers, 2019 to 2024 - An $11.6 Billion Opportunity, Analyzed by Type, Application, Location of Testing, and Region - ResearchAndMarkets.com

February 28, 2019

DUBLIN--(BUSINESS WIRE)--Feb 28, 2019--The “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering.

The global cardiac biomarkers market was worth US$ 6.9 Billion in 2018. Looking forward, the market value is projected to reach US$ 11.6 Billion by 2024, expanding at a CAGR of around 9% during 2019-2024.

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers.

In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack.

Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Market Summary

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.

Key Questions Answered

  • How has the global cardiac biomarkers market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global cardiac biomarkers industry?
  • What is the breakup of the global cardiac biomarkers market on the basis of type?
  • What is the breakup of the global cardiac biomarkers market on the basis of location of testing?
  • What is the breakup of the global cardiac biomarkers market on the basis of application?
  • What are the various stages in the value chain of the global cardiac biomarkers market?
  • What are the key driving factors and challenges in the global cardiac biomarkers market?
  • What is the structure of the global cardiac biomarkers market and who are the key players?
  • What is the degree of competition in the global cardiac biomarkers market?

Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Cardiac Biomarkers Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Type

5.4 Market Breakup by Location of Testing

5.5 Market Breakup by Application

5.6 Market Breakup by Region

5.7 Market Forecast

6 Market Breakup by Type

6.1 Troponins (T and I)

6.2 Myocardial Muscle Creatine Kinase (CK-MB)

6.3 Myoglobin

6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP

6.5 Ischemia Modified Albumin (IMA)

6.6 Others

7 Market Breakup by Location of Testing

7.1 Laboratory Testing

7.2 Point of Care Testing

8 Market Breakup by Application

8.1 Myocardial Infarction

8.2 Congestive Heart Failure

8.3 Acute Coronary Syndrome

8.4 Atherosclerosis

8.5 Others

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Middle East and Africa

9.5 Latin America

10 Global Cardiac Biomarkers Industry: SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

14.3.1 Abbott Laboratories

14.3.2 Alere Inc.

14.3.3 Beckman Coulter

14.3.4 Becton, Dickinson and Co.

14.3.5 bioMerieux

14.3.6 Bio-Rad Laboratories

14.3.7 Randox Laboratories

14.3.8 Roche Diagnostics Corporation

14.3.9 Siemens Healthcare

14.3.10 Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/mck8zs/the_global_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190228005430/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biomarkers

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/28/2019 06:47 AM/DISC: 02/28/2019 06:48 AM

http://www.businesswire.com/news/home/20190228005430/en